Sentences with phrase «new tumors in»

Malignant adrenal cancers may spread through the body by invading the adjacent blood vessels and seeding new tumors in body cavities and other organs.

Metastatic disease refers to cancer that has spread through the blood or lymph system to form new tumors in other parts of the body distinct from the original site.

The aggressive basal - type breast cancers often metastasize, seeding new tumors in distant parts of the body.

Not exact matches

A new study, conducted by the U.S. National Toxicology Program, found that rats consistently exposed to radiofrequency radiation from cellphones were more likely to develop malignant tumors in the brain and heart.

It has already invested in some companies that graduated from the Labs incubator, including Modern Meadow, a New Jersey — based startup that's biofabricating leather without the need for animals, and 3Scan, a company that enables 3D analysis of tumors and organs.

Dr. José Baselga, chief medical officer and physician - in - chief at Memorial Sloan Kettering Cancer Center in New York, says it's organizations such as the Kamen Brain Tumor Foundation that will be instrumental in driving the cure.

So even if a tumor is surgically removed, it is difficult to extract every cancerous cell; any left behind will result in the growth of a new tumor.

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Since they were approved in 2014, drugs that stimulate the immune system have been giving new hope to patients with melanoma, kidney cancer, lymphoma and other cancers, including famously to President Jimmy Carter, who credited the drug called Keytruda with shrinking tumors that had spread to his brain.

In contrast, the biologic approach injects a genetically engineered protein designed to knock out a tumor's ability to produce new blood vessels, thereby cutting off its capacity to grow.

Four days before Lent, I hold a tried and true friend's hand and she takes off her wig and looks me straight in the eye when she tells me that this new tumor's inoperable and this will be her Cancer 2.0.

In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cellIn 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cellin the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cellin mice and in lab cultures, and it also prevented the growth of new tumor cellin lab cultures, and it also prevented the growth of new tumor cells.

It was confirmed June 29 and I love the keto diet because not only is it helping me heal chemo side - effects from 2000/2001, I can feel a new freedom in my abdomen, I know it's clearing tumors away.

After John's diagnosis, when Isabella was in third grade, the family relocated from North Carolina to Michigan, then later, on to New York and Minnesota as John underwent surgeries to remove tumors, implant pain pumps and reconstruct parts of his skull.

Given the results of a a new study reported in the British medical journal, The Lancet4 that children and young adults scanned multiple times by CT have a small increased risk of leukemia and brain tumors in the decade following their first scan, parents should make sure a CT scan is really necessary in treatment of their child after head injury.

NEW YORK (CBSNewYork / AP)-- The New York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegatioNEW YORK (CBSNewYork / AP)-- The New York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegatioNew York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegations.

Just months after finding out he had metastatic cancer, former President Jimmy Carter announced this weekend that his doctors have said he no longer needs cancer treatment thanks in part to a groundbreaking new kind of medication that trains the immune system to fight cancer tumors.

«Cancer cells disguise themselves by switching off genes, new research reveals: A genome - wide map of the genes switched off in aggressive tumors reveals a «signature».»

They are trying to reproduce those results in a community setting and extend their models by adding new factors that describe how the tumor evolves.

These discoveries were made by oncologist Dr. Michael Kühn from the Department of Internal Medicine III, which is a part of the University Center for Tumor Diseases (UCT) at the Mainz University Medical Center, in a collaborative effort with researchers from the Memorial Sloan - Kettering Cancer Center in New York and Harvard University in Boston.

Revving up the immune system to combat a wide variety of tumor types may take cancer therapy in a new direction, says Khaled Barakat, a computational scientist at the University of Alberta in Canada, who was not involved in the study.

«Researchers are using newer technologies to look directly into tumors,» she says, «to make sure immunotherapies induce a response that works in the tumor.»

In conclusion, this new study identifies the cellular origin of Pik3ca - induced tumours and reveals that oncogenic Pik3ca activates a multipotent genetic program, setting the stage for future intratumoural heterogeneity at the earliest stage of tumor development.

They discovered that the chemicals and radiation used to kill tumor cells damage the stem cell reservoir in the hippocampus and nearly halt the formation of new neurons in both children and adults.

In a paper published in the May 5 online issue of The Oncologist, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board — a new type of advisory group comprised of multidisciplinary experts, including those in the fields of tumor genetics, basic science and bioinformaticIn a paper published in the May 5 online issue of The Oncologist, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board — a new type of advisory group comprised of multidisciplinary experts, including those in the fields of tumor genetics, basic science and bioinformaticin the May 5 online issue of The Oncologist, researchers at the University of California, San Diego School of Medicine and Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board — a new type of advisory group comprised of multidisciplinary experts, including those in the fields of tumor genetics, basic science and bioinformaticin the fields of tumor genetics, basic science and bioinformatics.

For some years now, a new class of drugs called antibody - drug conjugates (ADCs) have been used, which work in two ways: they consist of an antibody that binds selectively to the tumor cell receptor and interrupts the signal to propagate; they also act as a transport vehicle for a chemical substance that enters the cancer cells with the antibody and triggers their death.

«Several major advances in recent years have been good news for multiple myeloma patients, but those new drugs only target terminally differentiated cancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego Health.

In the new study, 72 percent of patients responded to the drug, meaning that their tumors shrank to some degree.

Led by Stella K. Kang, a radiologist with the Department of Radiology at the New York School of Medicine, the study was designed to compare the effectiveness of a treatment algorithm for small renal tumors incorporating the nephrometry score, a renal tumor anatomy scoring system developed by urologists, with the current standard of uniformly recommended partial nephrectomy in patients with mild - to - moderate chronic kidney disease (CKD).

Another possible application for the new machine is generating peptides that could be used as personalized cancer vaccines targeting unique proteins found in individual patients» tumors.

Traditional genetic approaches together with the new wealth of genomic information for both human and model organisms open up strategies by which drugs can be profiled for their ability to selectively kill cells in a molecular context that matches those found in tumors.

An old idea of retreating lung tumors with radiation is new again, especially with the technological advances seen in radiation oncology over the last decade.

In this new study published in Nature, Alexandra Van Keymeulen and colleagues used state of the art genetic mouse models to identify the cellular origin of PIK3CA and p53 induced breast tumorIn this new study published in Nature, Alexandra Van Keymeulen and colleagues used state of the art genetic mouse models to identify the cellular origin of PIK3CA and p53 induced breast tumorin Nature, Alexandra Van Keymeulen and colleagues used state of the art genetic mouse models to identify the cellular origin of PIK3CA and p53 induced breast tumors.

And in a new study, Cornell University researchers report that tumor cells take advantage of already - cleared paths to migrate unimpeded.

The new research, which is detailed in Biomaterials, showed that slow - release peptide gels could continuously deliver immunotherapy drugs to tumor sites for long periods of time.

Looking to target a key pathway in order to interfere with the processes that lead to tumor spread, a research team led by Irwin H. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and other malignant solid tumors.

But following the removal of the primary tumor, micrometastatic cells learn to communicate with cells in their new microenvironment in the brain — cells which are, at first, hostile to them.

That's because hospitals are equipped with powerful new scanning machines primarily used to identify tumors, ballooning blood vessels, bone fractures, and a wide range of disorders in people.

Dr. Del Maestro adds, «Yong and colleagues at the University of Calgary have begun to unravel the complex interaction of the microglia with the brain tumor cells, resulting not only in furthering our understanding, but providing a new concept and drug which can now be immediately assessed in clinical trials.»

Published in the February 27 issue of Cell, the study found that tumor cells that reach the brain — and successfully grow into new tumors — hug capillaries and express specific proteins that overcome the brain's natural defense against metastatic invasion.

Different changes to the microbial community of the stomach may explain why related conditions are associated with different risk levels and types of gastric tumor, according to a new study in PLOS Pathogens.

Dr. Sergio Lira and his team at the Icahn School of Medicine at Mount Sinai, New York, asked if gut microbes have a hand in tumor development.

And how do occasional cells survive in this vulnerable state — sometimes hiding out in the brain for years — to eventually spawn new tumors?

«This finding,» Villanueva said «opens the door to developing new biomarkers and new therapeutic strategies exploiting these characteristics of exosomes in breast tumors, and other tumors such as ovarian and endometrial cancer among others.»

Tumors are notoriously difficult to study in their natural habitat — body tissues — but a new synthetic tissue environment may give cancer researchers the next - best look at tumor growth and behavior.

As new oncogenic driver genes are identified, the testing process becomes less efficient because more genes need to be analyzed in limited amounts of tumor tissue.

Researchers at the University of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms in the spread of malignant tumors through the body.

She and her colleagues sequenced genomic DNA in the tumor samples but did not find any new driver gene mutations in the metastatic samples compared to the primary tumor samples, said McDonald, who completed clinical training under Iacobuzio - Donahue at Johns Hopkins.

Maria Zajac - Kaye, Ph.D., an associate professor in the College of Medicine's department of anatomy and cell biology, and Rony François, an M.D. / Ph.D. student who works with her, found a new drug combination that inhibits one form of pancreatic cancer tumor and kills its cells.

One form of pancreatic cancer has a new enemy: a two - drug combination discovered by UF Health researchers that inhibits tumors and kills cancer cells in mouse models.

This new study is believed to be the first reported to analyze the association between EGFR mutation status in tumor tissue and 18F labeled EGFR - TKI tracer uptake in NSCLC patients.